Vicapsys Life Sciences Inc (VICP)
US Market

Vicapsys Life Sciences (VICP) Financial Statements


Vicapsys Life Sciences Financial Overview

Vicapsys Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.03; its P/E ratio is -32.79; Vicapsys Life Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -135.69K$ -211.28K$ -492.61K$ -145.08K$ -180.06K
EBITDA$ -134.30K$ -211.28K$ -484.79K$ -137.26K$ -172.23K
Net Income Common Stockholders$ -135.69K$ 83.22K$ -492.61K$ -148.63K$ -180.06K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 231.28K$ 4.14K$ 14.10K$ 26.21K$ 17.29K
Total Assets$ 378.15K$ 63.29K$ 72.02K$ 383.80K$ 382.20K
Total Debt$ 263.11K$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 31.83K$ -4.14K$ -14.10K$ -26.21K$ -17.29K
Total Liabilities$ 1.47M$ 1.20M$ 1.02M$ 904.08K$ 848.80K
Stockholders Equity$ -1.09M$ -1.14M$ -950.79K$ -520.28K$ -466.59K
Cash Flow-
Free Cash Flow$ -218.10K$ -9.96K$ 2.89K$ -41.08K$ -84.03K
Operating Cash Flow$ -218.10K$ -9.96K$ 2.89K$ -41.08K$ -84.03K
Investing Cash Flow---$ 0.00$ 0.00
Financing Cash Flow$ 445.24K-$ -15.00K$ 50.00K-
Currency in USD

Vicapsys Life Sciences Earnings and Revenue History

Vicapsys Life Sciences Debt to Assets

Vicapsys Life Sciences Cash Flow

Vicapsys Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis